Clinical Trials
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8219
Evaluation of Combined or Sequential Chemo-Endocrine Therapy in the Treatment of Advanced Adenocarcinoma of the Prostate
Activated
08-11-1984
Closed
10-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8411
Evaluation of DTIC in Metastatic Carcinoid
Activated
07-20-1984
Closed
02-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8318
Evaluation of Fludarabine Phosphate in Hepatoma
Activated
07-20-1984
Closed
11-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8415
Evaluation of Tamoxifen in Unresectable and Refractory Meningiomas, Phase II
Activated
07-20-1984
Closed
07-01-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8384
Evaluation of Fludarabine Phosphate in Small Cell Lung Carcinoma TEMPORARILY CLOSED: 9/27/85
Activated
07-20-1984
Closed
03-20-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8410
Combination Chemotherapy of Intermediate and High- Grade Non-Hodgkin's Lymphoma with m-BACOD
Activated
07-20-1984
Closed
03-22-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8300
Treatment of Limited Non-Small Cell Lung Cancer: Radiation Versus Radiation Plus Chemotherapy (FOMi/CAP)
Research Committee(s)
Lung Cancer
Activated
07-20-1984
Closed
03-01-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8407
Evaluation of CBDCA (Diamine (1,1-Cyclobutane- Dicarboxylato-(2)-0,0')-(SP-4-2)Platinum, NSC-241240) in Advanced Endometrial Carcinoma
Activated
07-20-1984
Closed
09-01-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8402
Evaluation of Esorubicin in Ovarian Cancer
Activated
06-11-1984
Closed
12-15-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8408
Evaluation of Esorubicin (4'Deoxydoxorubicin) in Advanced Endometrial Carcinoma
Activated
06-11-1984
Closed
05-01-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8373
Evaluation of L-Phenyl-Alanine Mustard (Melphalan) in Patients with Metastatic Colorectal Carcinoma
Activated
06-11-1984
Closed
10-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8319
Evaluation of Fludarabine Phosphate in Ovarian Cancer
Activated
06-01-1984
Closed
06-30-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8328
Evaluation of Fludarabine Phosphate in Cervical Cancer
Activated
06-01-1984
Closed
03-18-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8320
Evaluation of Fludarabine Phosphate in Endometrial Cancer
Activated
06-01-1984
Closed
03-01-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8461
Registration and Evaluation of Patients Aged 55 and Over with Unfavorable Histology NHL
Activated
06-01-1984
Closed
03-20-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8323
Evaluation of Fludarabine Phosphate in Advanced Mycosis Fungoides
Activated
05-21-1984
Closed
05-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8322
Evaluation of Fludarabine Phosphate in Advanced Sarcomas
Activated
05-11-1984
Closed
10-01-1986
Closed
Phase
Accrual
96%
Published
SWOG Clinical Trial Number
SWOG-8312
Megestrol Acetate and Aminoglutethimide/ Hydrocortisone In Sequence or in Combination as Second-Line Endocrine Therapy of Estrogen Receptor Positive Metastatic Breast Cancer
Research Committee(s)
Breast Cancer
Activated
05-04-1984
Closed
11-15-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8316
Evaluation of Fludarabine Phosphate in Renal Cell Carcinoma
Activated
04-20-1984
Closed
03-22-1985
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8313 (EST 5186)
Multiple Drug Adjuvant Chemotherapy for Patients with ER Negative Stage II Carcinoma of Breast
Activated
04-20-1984
Closed
06-15-1990